Safety, efficacy, and DIVA feasibility on a novel live attenuated CSFV marker vaccine candidate. Tong C, Liu H, Wang J, Sun Y, et al. Vaccine 2022 Oct 31. pii: S0264-410X(22)01293.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tong C, Liu H, Wang J, Sun Y, et al. Safety, efficacy, and DIVA feasibility on a novel live attenuated CSFV marker vaccine candidate. Vaccine 2022 Oct 31. pii: S0264-410X(22)01293.
PMID: 36328881